NASDAQ

C4 Therapeutics, Inc. (CCCC)

♥ 648 Thanks from members

Live price chart, market sentiment, and community perspectives for C4 Therapeutics, Inc. (NASDAQ: CCCC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Lundbeck Ventures and founding scientistsLeadership: Nello Mainolfi (President and CEO)Holder: Bain Capital Life SciencesHolder: Boxer CapitalHolder: Vanguard GroupCC-90009Degrader-Antibody Conjugates (DACs)#CCCC stock#C4 Therapeutics#targeted protein degradation#NASDAQ CCCC#biotech clinical stage